Immersion Session- Imaging Therapeutic Response
0% Completed
Imaging Response Assessment in Therapeutic Clinical Trials
Imaging Therapeutic Response Immersion Scientific Session
On-demand Video
Video - 2:02:01 mins
Optically Labeled Therapeutic Antibodies Enable Direct Measurement of Tumor Receptor Occupancy for Dose Optimization in Solid Cancers
Reading
Trastuzumab PET imaging informs T-DXd/lovastatin treatment schedule in HER2-low and -ultralow breast tumors
Reading
Evaluation of Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Lu-177 PSMA Therapy
Reading
Tumor STING signaling Determines response to ²²⁵Ac-PSMA-617 Radioligand Therapy in prostate cancer
Reading
Interrogating Preventative Treatment Efficacy in Premalignant Pancreatic Lesions Using Hyperpolarized Magnetic Resonance
Reading
A biology-driven two-stage multiparametric imaging framework (quantitative T2 + [⁹⁹ᵐTc] Duramycin/SPECT) for glioma immunotherapy responses
Reading
Spatiotemporal Mapping of Molecular Delivery to Glioblastoma Using a First-in-Class Trimodal PET/MRI/FUS System
Reading
Intravesical disitamab vedotin-directed surface-enhanced spatially offset resonance Raman spectroscopic imaging and guided-therapy of HER2-expressing bladder cancer
Reading
Industry Sponsored Lunch
The Evolving Landscape of Imaging Therapeutic Response
Finish Course Early?
You have not completed all required lessons and assessments.
Your Progress
0%